Invesco Ltd. Kezar Life Sciences, Inc. Transaction History

Invesco Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.8 - $1.05 $988 - $1,296	-1,235 Reduced 5.96%	19,476 $17,000
Q4 2023 Feb 12, 2024	BUY	$0.72 - $1.15 $3,885 - $6,206	5,397 Added 35.24%	20,711 $19,000
Q3 2023 Nov 13, 2023	BUY	$1.08 - $2.54 $2,072 - $4,874	1,919 Added 14.33%	15,314 $18,000
Q2 2023 Aug 11, 2023	SELL	$2.31 - $3.06 $5,687 - $7,533	-2,462 Reduced 15.53%	13,395 $32,000
Q1 2023 May 12, 2023	SELL	$3.13 - $7.31 $2,732 - $6,381	-873 Reduced 5.22%	15,857 $49,000
Q4 2022 Feb 13, 2023	SELL	$6.39 - $8.8 $25 - $35	-4 Reduced 0.02%	16,730 $117,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $4,770 - $6,417	597 Added 3.7%	16,734 $144,000
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $1.79 Million - $6.7 Million	-390,999 Reduced 96.04%	16,137 $133,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $2.94 Million - $4.38 Million	-238,826 Reduced 36.97%	407,136 $6.77 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $4.71 Million - $10.6 Million	633,215 Added 4967.56%	645,962 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $6,615 - $13,271	1,364 Added 11.98%	12,747 $110,000
Q2 2021 Aug 17, 2021	BUY	$4.93 - $6.46 $3,130 - $4,102	635 Added 5.91%	11,383 $62,000
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $56,319 - $75,128	10,748 New	10,748 $64,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.